MicroPort/LivaNova JV’s Pacemaker Approved for China Use

Life Science

Novo Nordisk Approved to Launch New Diabetes Treatment in China

Life Science

CR Gosun In-Licenses Antibiotic from Basilea in $152 Million Deal

Life Science

Simcere to Market Four Amgen Biosimilars in China

Life Science

China News Weekly – China’s Ping An Technology aims to generate half its business from external customers

Financial Service, Life Science, Mining, Technology

What Sectors are Being Covered at the GCFF – Toronto Conference 2017?

Energy, Financial Service, Life Science, Mining, Precious Metals, Technology

Ping An Strategically Invests in Tsumura and Becomes Its Largest Shareholder

Life Science

Gilead Sciences Approved to Market HCV Drug in China

Life Science

Shandong Weigao Pays $850 Million to Acquire Argon Medical Devices

Life Science, Technology

Sisram Medical, Majority-Owned by Fosun, Stages $125 Million Hong Kong IPO

Life Science

Cofactor Genomics pulls in $18 million with the aim to save lives through RNA research

Life Science

Shuwen Biotech Approved for European Use of EGFR Test

Life Science

Fosun revises Indian drug maker acquisition, cuts stake size

Life Science

Shanghai United Imaging Healthcare Raises Record $500 Million at $5 Billion Valuation

Life Science

Spineology Raises $5 Million from Shanghai’s Hermed Capital

Life Science